Skip to search formSkip to main contentSkip to account menu

Cancer Stemness Kinase Inhibitor BBI503

Known as: BBI503 
An orally available cancer cell stemness kinase inhibitor with potential antineoplastic activity. Even though the exact target has not been fully… 
National Institutes of Health

Related topics

Related topics

1 relation
NCIt Antineoplastic Agent Terminology

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
LncGata6-controlled stemness in regeneration and cancer.
Long-noncodingRNAs (lncRNAs) have been proposed as a critical regulator of various cellularprocesses including cell fate decision… 
2017
2017
Abstract 20512: Metabolic Reprogramming of Cardiac Progenitor Cells by Lin28 Enhances Cardiac Repair Potential
Introduction: Cardiac progenitor cells (CPCs) possess incredible repair properties in the neonatal heart but are prone to disease… 
2015
2015
Abstract P2-06-05: Expression of the pluripotency transcription factor SOX2 in primary breast cancers (BCs): Correlation with clinicopathological features (CPfs) and recurrence
BACKGROUND SOX2 is one of the pluripotency transcription factors expressed by stem cells, which plays a central role in… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)